Search citation statements
Paper Sections
Citation Types
Publication Types
Relationship
Authors
Journals
Practice Problem: Human Immunodeficiency Virus (HIV) is one of the leading pandemics in the world. In 2019, 38 million people were living with HIV around the world. Of those, roughly 87% were aware of their HIV status. PICOT: In patients with high risk for HIV, how does implementing a pre-exposure (PrEP) screening tool compared to randomly screening for pre-exposure prophylaxis (PrEP) affect the prescribing of pre-exposure prophylaxis (PrEP) within eight weeks? Evidence: In 2015, the World Health Organization (WHO) recommended PrEP for the prevention of HIV in high-risk individuals. The patients include men who have sex with men, sex workers, individuals with multiple sex partners, and intravenous drug users. In 2021, only about 25% of individuals with high-risk for HIV are utilizing PrEP. Intervention: There are two interventions in this research: PrEP screening tool and prescription of PrEP. Outcome: An increase in the number of those screened for the use of PrEP increased dramatically from previous screening. Although the percentage goal of those prescribed PrEP was not met, there was an increase in those prescribed PrEP compared to previous prescribing methods. Conclusion: In conclusion, the use of a PrEP screening tool in general practice can increase the use of PrEP in high-risk populations. The best way to stop the HIV pandemic is to utilize the best prevention available, which is PrEP. Using a PrEP screening tool in clinics not knowledgeable on PrEP will increase the prescribing of PrEP.
Practice Problem: Human Immunodeficiency Virus (HIV) is one of the leading pandemics in the world. In 2019, 38 million people were living with HIV around the world. Of those, roughly 87% were aware of their HIV status. PICOT: In patients with high risk for HIV, how does implementing a pre-exposure (PrEP) screening tool compared to randomly screening for pre-exposure prophylaxis (PrEP) affect the prescribing of pre-exposure prophylaxis (PrEP) within eight weeks? Evidence: In 2015, the World Health Organization (WHO) recommended PrEP for the prevention of HIV in high-risk individuals. The patients include men who have sex with men, sex workers, individuals with multiple sex partners, and intravenous drug users. In 2021, only about 25% of individuals with high-risk for HIV are utilizing PrEP. Intervention: There are two interventions in this research: PrEP screening tool and prescription of PrEP. Outcome: An increase in the number of those screened for the use of PrEP increased dramatically from previous screening. Although the percentage goal of those prescribed PrEP was not met, there was an increase in those prescribed PrEP compared to previous prescribing methods. Conclusion: In conclusion, the use of a PrEP screening tool in general practice can increase the use of PrEP in high-risk populations. The best way to stop the HIV pandemic is to utilize the best prevention available, which is PrEP. Using a PrEP screening tool in clinics not knowledgeable on PrEP will increase the prescribing of PrEP.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.